• Users Online: 537
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 3  |  Issue : 1  |  Page : 44-52

Coronary angioplasty: Back to the future

1 Department of Cardiology, Consultant Cardiologist, Care Hospital, Hi-Tech City, Hyderabad, India
2 Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, K.R. Hospital Campus, Mysore, Karnataka, India

Correspondence Address:
Nilkanth Chandrakant Patil
Metro Hospital and Heart Institute, X-1, Secotor 12, Noida, Uttar Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpcs.jpcs_1_17

Rights and Permissions

Puel and Sigwart, in 1986, deployed the first coronary stent to act as a scaffold preventing vessel closure reducing the incidence of angiographic restenosis. The first stents were bare metal stents. The first drug-eluting stents to be approved were coated with paclitaxel or sirolimus. Since these stents came with a lot of promise but also with risk of thrombosis, the next step was biodegradable stents. These stents are expected to degrade into nontoxic byproducts. They came with a lot of fanfare but are now being viewed with caution because of initial poor results. We do not know what the future holds.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded381    
    Comments [Add]    

Recommend this journal